참고문헌
- Adamczyk A, Niemiec J, Janecka A, et al (2015). Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting. Pol J Pathol, 66, 133-41.
- Adzhubei IA, Schmidt S, Peshkin L, et al (2010). A method and server for predicting damaging missense mutations. Nat Methods, 7, 248-9. https://doi.org/10.1038/nmeth0410-248
- Black JL, Harrell JC, Leisner TM, et al (2015). CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer. Breast Cancer Res Treat, 152, 337-46. https://doi.org/10.1007/s10549-015-3458-4
- Cariaso M, Lennon G (2012). SNPedia: a wiki supporting personal genome annotation, interpretation and analysis. Nucleic Acids Res, 40, 1308-12. https://doi.org/10.1093/nar/gkr798
- Caserta E, Egriboz O, Wang H, et al (2015). Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev, 29, 1707-20. https://doi.org/10.1101/gad.262568.115
- Cheng J, Randall A, Baldi P (2006). Prediction of protein stability changes for single-site mutations using support vector machines. Proteins, 62, 1125-32.
- Choi Y, Sims GE, Murphy S, et al (2012). Predicting the functional effect of amino acid substitutions and indels. PLoS One, 7, 46688. https://doi.org/10.1371/journal.pone.0046688
- DeGraffenried LA, Fulcher L, Friedrichs WE, et al (2004). Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway. Ann Oncol, 15, 1510-6. https://doi.org/10.1093/annonc/mdh388
- Dehouck Y, Grosfils A, Folch B, et al (2009). Fast and accurate predictions of protein stability changes upon mutations using statistical potentials and neural networks: PoPMuSiC-2.0. Bioinformatics, 25, 2537-43. https://doi.org/10.1093/bioinformatics/btp445
- DeSantis C, Ma J, Bryan L, et al (2014). Breast cancer statistics, 2013. CA Cancer J Clin, 64, 52-62. https://doi.org/10.3322/caac.21203
- Fraczkiewicz R, Braun W (1998). Exact and Efficient Analytical Calculation of the Accessible Surface Areas and Their Gradients for Macromolecules. J Comp Chem, 19, 319-33. https://doi.org/10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W
- Gonzalez-Angulo AM, Ferrer-Lozano J, Stemke-Hale K, et al (2011). PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer. Mol Cancer Ther, 10, 1093-101. https://doi.org/10.1158/1535-7163.MCT-10-1089
- Haiman CA, Stram DO, Cheng I, et al (2006). Common genetic variation at PTEN and risk of sporadic breast and prostate cancer. Cancer Epidemiol Biomarkers Prev, 15, 1021-5. https://doi.org/10.1158/1055-9965.EPI-05-0896
- Heikkinen T, Greco D, Pelttari LM, et al (2011). Variants on the promoter region of PTEN affect breast cancer progression and patient survival. Breast Cancer Res, 13, 130. https://doi.org/10.1186/bcr3076
- International HapMap C, Altshuler DM, Gibbs RA, et al (2010). Integrating common and rare genetic variation in diverse human populations. Nature, 467, 52-8. https://doi.org/10.1038/nature09298
- Kechagioglou P, Papi RM, Provatopoulou X, et al (2014). Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression. Anticancer Res, 34, 1387-400.
- Kumar P, Henikoff S, Ng PC (2009). Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc, 4, 1073-81. https://doi.org/10.1038/nprot.2009.86
- Kwan ML, Kushi LH, Weltzien E, et al (2009). Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res, 11, 31.
- Lee JO, Yang H, Georgescu MM, et al (1999). Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell, 99, 323-34. https://doi.org/10.1016/S0092-8674(00)81663-3
- Lindahl E, Azuara C, Koehl P, et al (2006). NOMAD-Ref: visualization, deformation and refinement of macromolecular structures based on all-atom normal mode analysis. Nucleic Acids Res, 34, 52-6.
- Maggi LB, Jr., Weber JD (2015). Targeting PTEN-defined breast cancers with a one-two punch. Breast Cancer Res, 17, 51. https://doi.org/10.1186/s13058-015-0566-3
- Martin AM, Weber BL (2000). Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst, 92, 1126-35. https://doi.org/10.1093/jnci/92.14.1126
- Ng PC, Henikoff S (2003). SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res, 31, 3812-4. https://doi.org/10.1093/nar/gkg509
- Ng PC, Henikoff S (2006). Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet, 7, 61-80. https://doi.org/10.1146/annurev.genom.7.080505.115630
- Saika K, Sobue T (2013). [Cancer statistics in the world]. Gan To Kagaku Ryoho, 40, 2475-80.
- Schaefer C, Meier A, Rost B, et al (2012). SNPdbe: constructing an nsSNP functional impacts database. Bioinformatics, 28, 601-2. https://doi.org/10.1093/bioinformatics/btr705
- Sherry ST, Ward MH, Kholodov M, et al (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Res, 29, 308-11. https://doi.org/10.1093/nar/29.1.308
- Sood A, Ghosh AK (2006). Literature search using PubMed: an essential tool for practicing evidence- based medicine. J Assoc Physicians India, 54, 303-8.